Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction

Diabetologia

Volumn 48, Issue 5, 2005, Pages 856-861

  Hu, G ^a,b   Jousilahti, P ^a,b   Qiao, Q ^a,b   Katoh, S ^a,c   Tuomilehto, J ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular disease; Coronary heart disease; Gender difference; Myocardial infarction; Type 2 diabetes

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEALTH SURVEY; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REGISTER; SAMPLE SIZE; SEX DIFFERENCE; SMOKING; STROKE;

ADULT; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; DIABETIC ANGIOPATHIES; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; SEX CHARACTERISTICS; SMOKING;

EID: 20044380769     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1730-6     Document Type: Article

References (26)

1. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431
2. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053
3. Muller WA (1998) Diabetes mellitus - long time survival. J Insur Med 30:17-27
4. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234
5. DECODE Study Group (2003) Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 46:608-617
6. Becker A, Bos G, de Vegt F et al (2003) Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease: 10-year follow-up of the Hoorn Study. Eur Heart J 24:1406-1413
7. Natarajan S, Liao Y, Cao G, Lipsitz SR, McGee DL (2003) Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 163:1735-1740
8. Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P (2000) Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol 29:49-56
9. World Health Organization MONICA Project Principal Investigators (1988) The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 41:105-114
10. Pajak A, Kuulasmaa K, Tuomilehto J, Ruokokoski E (1988) Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years: the WHO MONICA project. World Health Stat Q 41:115-140
11. Mahonen M, Salomaa V, Brommels M et al (1997) The validity of hospital discharge register data on coronary heart disease in Finland. Eur J Epidemiol 13:403-415
12. World Health Organization Study Group on Diabetes Mellitus (1985) Diabetes mellitus: report of a WHO study group. WHO Technical Report Series No. 727. World Health Organization, Geneva
13. Waterhouse J, Muir C, Correa P, Powell J (1976) Cancer incidence in five continents. IARC Scientific Publications, Lyon
14. Hu FB, Stampfer MJ, Solomon CG et al (2001) The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 161:1717-1723
15. Lotufo PA, Gaziano JM, Chae CU et al (2001) Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med 161:242-247
16. Evans JM, Wang J, Morris AD (2002) Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross-sectional and cohort studies. BMJ 324:939-942
17. Lee CD, Folsom AR, Pankow JS, Brancati FL (2004) Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation 109:855-860
18. Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J (2004) Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med 164:1438-1443
19. Siegel RD, Cupples A, Schaefer EJ, Wilson PW (1996) Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study. Metabolism 45:1267-1272
20. Curb JD, Pressel SL, Cutler JA et al (1996) Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 276:1886-1892
21. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703-713
22. Tuomilehto J, Rastenyte D, Birkenhager WH et al (1999) Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med 340:677-684
23. The ALLHAT Officers and Coordinators for the Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 288:2981-2997
24. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G (1997) Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian simvastatin survival study (4S). Diabetes Care 20:614-620
25. Heart Protection Study Collaborative Group (2002) MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7-22
26. Goldberg RB, Mellies MJ, Sacks FM et al (1998) Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation 98:2513-2519